Log In
Print this Print this

montelukast sodium (Kipres OD Tablets)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionOrally disintegrating tablet of montelukast sodium, a cysteinyl leukotriene receptor 1 (CysLT1) antagonist
Molecular Target Cysteinyl leukotriene receptor 1 (CysLT1)
Mechanism of ActionCysteinyl leukotriene receptor 1 (CysLT1) antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today